References
Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, et al. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. New England Journal of Medicine 324: 1098–1104, 1991
Croog SH, Levine S, Testa MA, Brown B, Bulpitt CH, et al. The effects of antihypertensive therapy on the quality of life. New England Journal of Medicine 314: 1657–1664, 1986
Cutler JA, MacMahon SW, Furberg CD. Controlled clinical trials of drug treatment for hypertension. A review. Hypertension 13 (Suppl. I): I36–I44, 1989
Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR. The Jcurve phenomenon and the treatment of hypertension. Journal of the American Medical Association 265: 489–495, 1991
Joint National Committee 1988: The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Archives of Internal Medicine 148: 1023–1038, 1988
Kaplan NM. Clinical Hypertension, 5th ed. Williams and Wilkins, Baltimore, 1990a
Kaplan NM. Changing hypertension treatment to reduce the overall cardiovascular risk. Journal of Hypertension 8 (Suppl. 7): S175–S179, 1990b
Kaplan NM. New approaches for the treatment of hypertension. Cardiovascular Drugs and Therapy, in press
Lithell HOL. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 14: 203–209, 1991
Warram JH, Laffel LMB, Valsania P, Christlieb AR, Krolewski AS. Excess mortality associated with diuretic therapy in diabetes mellitus. Archives of Internal Medicine 151: 1350–1356, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaplan, N.M. Introduction. Drug Invest 3 (Suppl 4), 1–2 (1991). https://doi.org/10.1007/BF03259525
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259525